Zobrazeno 1 - 10
of 72
pro vyhledávání: '"chronic myelomonocytic leukemia (CMML)"'
Autor:
Anwarul Islam
Publikováno v:
Clinical Case Reports, Vol 11, Iss 8, Pp n/a-n/a (2023)
Key Clinical Message Hypomethylating agents may be useful in some but not all cases of myelodysplastic syndromes. In some versions of these conditions, this treatment may yield deleterious results. Abstract Chronic myelomonocytic leukemia (CMML) is c
Externí odkaz:
https://doaj.org/article/bcf90a8bd7104d938378749867854f3c
Autor:
Argiris Symeonidis, Spiros Chondropoulos, Evgenia Verigou, Vasileios Lazaris, Alexandra Kourakli, Panagiotis Tsirigotis
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Chronic myelomonocytic leukemia (CMML) and the remaining, less frequent hybrid, mixed, or overlap myelodysplastic syndromes/myeloproliferative neoplasms (MDSs/MPNs) are difficult to treat neoplastic hematological disorders, exhibiting substantial cli
Externí odkaz:
https://doaj.org/article/b879f913d1e248e7beacdf3348b4f1a6
Autor:
Kazuki Taoka, Shunya Arai, Keisuke Kataoka, Masataka Hosoi, Masashi Miyauchi, Sho Yamazaki, Akira Honda, Wei Aixinjueluo, Takashi Kobayashi, Keiki Kumano, Akihide Yoshimi, Makoto Otsu, Akira Niwa, Tatsutoshi Nakahata, Hiromitsu Nakauchi, Mineo Kurokawa
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-13 (2018)
Abstract Chronic myelomonocytic leukemia (CMML) is an entity of myelodysplastic syndrome/myeloproliferative neoplasm. Although CMML can be cured with allogeneic stem cell transplantation, its prognosis is generally very poor due to the limited effica
Externí odkaz:
https://doaj.org/article/ca6c14c5e42546afa52dabe821a5a19d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
Chronic myelomonocytic leukemia (CMML) is a rare clonal haematological malignancy bearing characteristics of both myelodysplastic syndromes and myeloproliferative neoplasms. It primarily affects older people (median age at diagnosis ~72 years). There
Publikováno v:
Oxford Medical Case Reports
Hematological malignancies need special attention in the intensive care unit (ICU). Leukemia has numerous presentations in the ICU. Most commonly, these patients present with complications of therapy. Infection and neutropenia are major reasons for I
Autor:
Phuong L. Nguyen, Mazen Osman, Ahmad Nanaa, Zeynettin Akkus, Dragan Jevremovic, Aref Al-Kali, Mohamed E. Salama, Mrinal M. Patnaik, Samia Rizk, Dana Roh
Publikováno v:
Journal of Clinical Medicine
Volume 10
Issue 11
Journal of Clinical Medicine, Vol 10, Iss 2264, p 2264 (2021)
Volume 10
Issue 11
Journal of Clinical Medicine, Vol 10, Iss 2264, p 2264 (2021)
The accurate diagnosis of chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML) subtypes with monocytic differentiation relies on the proper identification and quantitation of blast cells and blast-equivalent cells, including promon
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Masataka Hosoi, Keiki Kumano, Kazuki Taoka, Tatsutoshi Nakahata, Mineo Kurokawa, Akihide Yoshimi, Hiromitsu Nakauchi, Wei Aixinjueluo, Takashi Kobayashi, Sho Yamazaki, Akira Honda, Makoto Otsu, Akira Niwa, Shunya Arai, Masashi Miyauchi, Keisuke Kataoka
Publikováno v:
Scientific Reports
Scientific Reports, Vol 8, Iss 1, Pp 1-13 (2018)
Scientific Reports, Vol 8, Iss 1, Pp 1-13 (2018)
Chronic myelomonocytic leukemia (CMML) is an entity of myelodysplastic syndrome/myeloproliferative neoplasm. Although CMML can be cured with allogeneic stem cell transplantation, its prognosis is generally very poor due to the limited efficacy of che